Ferumoxytol, Iron sucrose — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-08-31 in 25d
ESTIMATED |
READOUT
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmaco
Phase 3 · Chronic Kidney Disease; Iron Deficiency Anemia |
AMAG Pharmaceuticals, Inc. | Ferumoxytol, Iron sucrose |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|